Thank you to all veterans for your service and sacrifice. We are grateful for everything you’ve done to protect our freedoms.?#VeteransDay
关于我们
Kaléo is dedicated to inventing, manufacturing & commercializing life-transforming products that protect and empower patients and families to live fuller, bolder lives.
- 网站
-
https://www.kaleo.com
Kaléo的外部链接
- 所属行业
- 制药业
- 规模
- 201-500 人
- 总部
- Richmond，Virginia
- 类型
- 私人持股
- 创立
- 2005
- 领域
- Pharmaceuticals、Human Factors Engineering (HFE)、Biotechnology、Medical Countermeasures和Auto-Injectors
地点
-
主要
获取路线
111 Virginia St
US，Virginia，Richmond，23219
Kaléo员工
动态
-
Kaléo is pleased to welcome Theresa Matkovits, Ph.D. as Chief Development Officer. Dr. Matkovits brings extensive experience in global drug development and commercialization. With her leadership, we look forward to advancing our innovative Aerio? Auto-Injector Platform and strengthening our position in medical countermeasures. Read the full announcement at https://bit.ly/matkovits #Kaléo #Pharmaceuticals #Leadership
-
-
Hoping everyone has a safe and celebratory July 4th. #IndependenceDay #July4th #MedicalCountermeasures
-
-
We are proud to announce that Biomedical Advanced Research and Development Authority (BARDA) has selected Kaléo to develop the next generation pralidoxime chloride (2-PAM) auto-injector as a medical countermeasure against nerve agent poisoning. “The contract tasks Kaléo with developing a 2-PAM auto-injector for U.S. Food and Drug Administration (FDA) approval within 3 years, with an ultimate goal of enabling later procurement of the 2-PAM auto-injectors for BARDA’s CHEMPACK program,” said Mark Herzog, Kaleo’s VP for Global Corporate Affairs, Defense and Homeland Security. Kaléo is a market leader in emergency use auto-injectors with more than 12 million devices manufactured to meet the FDA’s standard of 99.999% device reliability. Read our full announcement here: https://bit.ly/2PAM_AI #Kaleo #MCM #medicalcountermeasure #CHEMPACK #BARDA #publichealth
-